Article | October 4, 2011

Decreasing Total Manufacturing Costs Using A Chemically Defined Supplement As Compared To Legacy Peptones

By Sam Denby, Ph.D., Chuck Velnoskey and Elizabeth Dodson, Ph.D., BD Biosciences – Advanced Bioprocessing

This article demonstrates a 12% decrease total cost-in-use for mammalian cell biopharmaceutical manufacturing by using a chemically defined supplement compared to a legacy process using peptones.

access the Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)